Alphina Therapeutics

Funding and NIH signals

• SEC Form D raise Raised $154K (Form D filed Mar 16, 2026). SEC Form D 0001882991-26-000003 (Mar 16, 2026)
  Evidence (1 event)

  • Mar 16, 2026 · SEC Form D 0001882991-26-000003
    Name of Issuer: Alphina Therapeutics, Inc.; CIK: 1882991; Address: New Haven, CT; Submission type: D; Filing date: 2026-03-16; Industry Group: Biotechnology; Date of First Sale: 2026-02-23; Types of Securities Offered: Option/warrant, Other (Simple Agreements for Future Equity (SAFEs)); Business combination transaction: false; Total Offering Amount: 10000000; Total Amount Sold: 153715; Federal exemptions: 06b

Job counts as of Oct 18, 2026. All funding and NIH signals